However, poly IC treatment augmented airway eosinophilia under a mast cell-derived PGD2-deficient or a BLT1-deficient condition, suggesting that neither mast cell-derived PGD2 nor BLT1 is responsible for the dsRNA-induced augmentation of airway eosinophilia. This evidence concerns the gene LTB4R and Increased total eosinophil count.